Background Adrenocortical carcinoma (ACC) is a rare and aggressive malignancy with
limited therapeutic options beyond surgical resection. The characteristics of actual long‐term …

Background We sought to define the impact of cortisol-secreting status on outcomes after
surgical resection of adrenocortical carcinoma (ACC). Methods The US ACC group …

Context Adrenocortical carcinomas (ACC) are a rare tumor type with a poor five-year
survival rate and limited treatment options. Objective Understanding of the molecular …

The pathogenetic mechanisms underlying the onset of adrenocortical tumors (ACTs) are still
largely unknown. Recently, more attention has been paid to the role of insulin and insulin …

Background It has been demonstrated that chloroquine (CQ) enhances the efficacy of
chemotherapy. However, little is known about whether CQ could enhance the efficacy of …

Adrenocortical carcinoma (ACC) has a dismal prognosis in advanced stages. Despite
treatment with the adrenal toxicant mitotane and/or aggressive chemotherapy, tumor control …

Background Appropriate use of laparoscopic adrenalectomy (LA) for adrenocortical
carcinoma (ACC) remains controversial because complete resection with negative margins …

Context: Retinoic acid receptor responder protein 2 (RARRES2) is a small secreted protein
involved in multiple cancers, including adrenocortical carcinoma (ACC). However …

Purpose Adequate tumour resection is the gold standard of care for adrenocortical
carcinoma (ACC). However, the optimal surgical strategy remains debatable. In our opinion …

Aim Ovarian corticosteroid-producing tumors are exquisitely rare. Our aim was to describe
the first case observed in our practice. Case history A 34-year-old female was referred for …